These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31929115)

  • 1. Metabolomic profiling of dried blood spots reveals gender-specific discriminant models for the diagnosis of small cell lung cancer.
    Yu L; Li K; Li X; Guan C; Sun T; Zhang X
    Aging (Albany NY); 2020 Jan; 12(1):978-995. PubMed ID: 31929115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Highly Efficient Gene Expression Programming (GEP) Model for Auxiliary Diagnosis of Small Cell Lung Cancer.
    Yu Z; Lu H; Si H; Liu S; Li X; Gao C; Cui L; Li C; Yang X; Yao X
    PLoS One; 2015; 10(5):e0125517. PubMed ID: 25996920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of lung cancer based on serum biomarkers by gene expression programming methods.
    Yu Z; Chen XZ; Cui LH; Si HZ; Lu HJ; Liu SH
    Asian Pac J Cancer Prev; 2014; 15(21):9367-73. PubMed ID: 25422226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Chemotherapeutic Efficacy in Non-Small Cell Lung Cancer by Serum Metabolomic Profiling.
    Tian Y; Wang Z; Liu X; Duan J; Feng G; Yin Y; Gu J; Chen Z; Gao S; Bai H; Wan R; Jiang J; Liu J; Zhang C; Wang D; Han J; Zhang X; Cai L; He J; Wang J
    Clin Cancer Res; 2018 May; 24(9):2100-2109. PubMed ID: 29437793
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolomic-based biomarker discovery for non-invasive lung cancer screening: A case study.
    O'Shea K; Cameron SJ; Lewis KE; Lu C; Mur LA
    Biochim Biophys Acta; 2016 Nov; 1860(11 Pt B):2682-7. PubMed ID: 27423423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
    Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
    J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New ARCHITECT plasma pro-gastrin-releasing peptide assay for diagnosing and monitoring small-cell lung cancer.
    Nisman B; Nechushtan H; Biran H; Peled N; Gantz-Sorotsky H; Doviner V; Perelman M; Bar J; Onn A; Uziely B; Peretz T
    Br J Cancer; 2016 Feb; 114(4):469-76. PubMed ID: 26812573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotransformation-based metabolomics profiling method for determining and quantitating cancer-related metabolites.
    Yue X; He J; Zhang R; Xu J; Zhou Z; Zhang R; Bi N; Wang Z; Sun C; Wang L; Chen Y; Abliz Z
    J Chromatogr A; 2018 Dec; 1580():80-89. PubMed ID: 30473010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiating Small-Cell Lung Cancer From Non-Small-Cell Lung Cancer Brain Metastases Based on MRI Using Efficientnet and Transfer Learning Approach.
    Grossman R; Haim O; Abramov S; Shofty B; Artzi M
    Technol Cancer Res Treat; 2021; 20():15330338211004919. PubMed ID: 34030542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Small and Non-Small Cell Lung Cancer Markers in Peripheral Blood Using Cytokinesis-Blocked Micronucleus and Spectral Karyotyping Assays.
    El-Zein RA; Abdel-Rahman S; Santee KJ; Yu R; Shete S
    Cytogenet Genome Res; 2017; 152(3):122-131. PubMed ID: 28898877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two plasma microRNA panels for diagnosis and subtype discrimination of lung cancer.
    Lu S; Kong H; Hou Y; Ge D; Huang W; Ou J; Yang D; Zhang L; Wu G; Song Y; Zhang X; Zhai C; Wang Q; Zhu H; Wu Y; Bai C
    Lung Cancer; 2018 Sep; 123():44-51. PubMed ID: 30089594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum pleiotrophin could be an early indicator for diagnosis and prognosis of non-small cell lung cancer.
    Du ZY; Shi MH; Ji CH; Yu Y
    Asian Pac J Cancer Prev; 2015; 16(4):1421-5. PubMed ID: 25743809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and therapeutic value of progastrin-releasing peptide on small-cell lung cancer: A Single-Center Experience in China.
    Wu XY; Hu YB; Li HJ; Wan B; Zhang CX; Zhang B; Hu H; Zhang Q; Lv TF; Zhan P; Song Y
    J Cell Mol Med; 2018 Sep; 22(9):4328-4334. PubMed ID: 29989303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma miR-92a-2 as a biomarker for small cell lung cancer.
    Yu Y; Zuo J; Tan Q; Zar Thin K; Li P; Zhu M; Yu M; Fu Z; Liang C; Tu J
    Cancer Biomark; 2017; 18(3):319-327. PubMed ID: 28106539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulinoma-associated protein 1 is a novel diagnostic marker of small cell lung cancer in bronchial brushing and cell block cytology from pleural effusions: Validity and reliability with cutoff value.
    Abe H; Takase Y; Sadashima E; Fukumitsu C; Murata K; Ito T; Kawahara A; Naito Y; Akiba J
    Cancer Cytopathol; 2019 Sep; 127(9):598-605. PubMed ID: 31436913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of Serum ELAVL4 (HuD) Antigen Assay for Small Cell Lung Cancer Diagnosis.
    Wang F; Lu J; Li S; Huo X; Liu X; Du X; Li C; Wang J; Chen Z
    Anticancer Res; 2017 Aug; 37(8):4515-4522. PubMed ID: 28739747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass spectrometric identification, characterization and validation of the haptoglobin β-chain protein as a lung cancer serum biomarker.
    Ayyub A; Saleem M; Musharraf SG; Naz M; Tariq A; Hashmi N
    Mol Med Rep; 2015 Sep; 12(3):3755-3762. PubMed ID: 26005016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analyzing the percentage of different PD-1
    Hu X; Gu Y; Li D; Zhao S; Hua S; Jiang Y
    Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1074-1083. PubMed ID: 31381177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of serum NY-ESO-1 antibody assay for early SCLC diagnosis.
    Yang J; Jiao S; Kang J; Li R; Zhang G
    Int J Clin Exp Pathol; 2015; 8(11):14959-64. PubMed ID: 26823828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortisol, cortisone, and 4-methoxyphenylacetic acid as potential plasma biomarkers for early detection of non-small cell lung cancer.
    Xiang C; Jin S; Zhang J; Chen M; Xia Y; Shu Y; Guo R
    Int J Biol Markers; 2018 Aug; 33(3):314-320. PubMed ID: 29896992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.